The voltage-gated potassium channel KV1. 3 as a therapeutic target for venom-derived peptides

G Tajti, DCC Wai, G Panyi, RS Norton - Biochemical pharmacology, 2020 - Elsevier
The voltage-gated potassium channel KV 1.3 is a well-established therapeutic target for a
range of autoimmune diseases, in addition to being the site of action of many venom-derived …

Risk of Clostridioides difficile infection in inflammatory bowel disease patients undergoing vedolizumab treatment: a systematic review and meta-analysis

W Chen, Y Liu, Y Zhang, H Zhang, C Chen, S Zhu… - BMC …, 2024 - Springer
Background Inflammatory bowel disease (IBD) is a chronic, relapsing condition wherein
biologics have improved disease prognosis but introduced elevated infection susceptibility …

Associations of inflammatory bowel disease and subsequent cancers in a population-based study of older adults in the United States

JH Wang, M D'Arcy, EL Barnes… - JNCI Cancer …, 2022 - academic.oup.com
Background Cancer risk is elevated in patients with inflammatory bowel disease (IBD). A
comprehensive investigation of cancer risk in older patients (≥ 66 years of age) is needed …

Real-world effectiveness and safety of advanced therapies for the treatment of moderate-to-severe ulcerative colitis: Evidence from a systematic literature review

PM Irving, P Hur, R Gautam, X Guo… - Journal of Managed Care …, 2024 - jmcp.org
BACKGROUND: Effectiveness and safety of advanced therapies for ulcerative colitis (UC)
warrant assessment in the real world. OBJECTIVE: To perform a systematic review and …

[引用][C] Hidradenitis Suppurativa Caused by Vedolizumab.

G Licata, A Gambardella, A De Rosa… - Dermatitis: Contact …, 2021 - europepmc.org
Hidradenitis Suppurativa Caused by Vedolizumab. - Abstract - Europe PMC Sign in | Create
an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us …